Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma refractory

Recruiting

InvestigationalNo placebo

Phase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Hereditary angioedema

Recruiting

Investigational

Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:ADX-324

Contact Research Centre

Myelofibrosis+1

Recruiting

Registered drug

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Neuroendocrine carcinoma

Recruiting

Registered drugNo placebo

Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Obesity

Recruiting

Investigational

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Obesity

Recruiting

Investigational

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Graves' disease

Recruiting

InvestigationalNo placebo

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Type 2 diabetes mellitus+2

Recruiting

Investigational

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Kidney transplant rejection

Recruiting

Registered drugNo placebo

Frexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Frexalimab

Contact Research Centre

Acute promyelocytic leukaemia

Recruiting

Registered drugNo placebo

Treatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Arsenic Trioxide

Contact Research Centre

A study to assess the safety of Anumigilimab in adults with sickle cell disease

Recruiting

Investigational

A study to assess the safety of Anumigilimab in adults with sickle cell disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:ANUMIGILIMAB

Contact Research Centre

Find therapies in clinical trials near you – page 3

382 trials match your criteria

Plasma cell myeloma refractory

Phase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments

Hereditary angioedema

Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

Myelofibrosis+1

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Hormone-dependent prostate cancer

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Neuroendocrine carcinoma

Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

Obesity

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Obesity

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Graves' disease

Long-Term Study of Imeroprubart in Adults With Graves' Disease

Type 2 diabetes mellitus+2

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Kidney transplant rejection

Frexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients

Acute promyelocytic leukaemia

Treatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia

A study to assess the safety of Anumigilimab in adults with sickle cell disease

A study to assess the safety of Anumigilimab in adults with sickle cell disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.